Kyverna Therapeutics
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases. Learn more
Launch date
Employees
Market cap
CAD424m
Enterprise valuation
(CAD35m) (Public information from Sep 2024)
Share price
$6.92 KYTX
Berkeley California (HQ)
Authorizing premium user...